⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

QELL News

Human Leukocyte Antigen (HLA) Targeted Therapy Market Research 2026: Advances Driven by Novel CAR-Treg and Bispecific T-Cell Engager Programs from Quell Therapeutics and Daiichi Sankyo